Nägele H, Döring V, Kalmár P, Schmidek G, Stubbe H H, Rödiger W
Chirurgische Klinik, Hamburg, Germany.
J Heart Lung Transplant. 1998 Sep;17(9):906-12.
Exercise capacity after heart transplantation (HTx) may be limited by sinus node disease of the donor heart and atrioatrial dissociation. The role of pacemaker therapy in this setting is not well defined. The purpose of this study was to compare clinical and hemodynamic data of heart transplant recipients with acquired sinus node disease treated with atrial synchronized pacing and patients with other pacing modes or without pacemakers 1 year after operation.
Our cohort comprises a total of 112 HTx recipients from the years 1984 to 1996. Atrial synchronized pacing was performed in 21 patients with donor sinus node disease and recipient sinus rhythm. There was no associated morbidity or death for the pacemaker implantation. Fourteen patients received a dual-chamber pacemaker programmed with a short atrioventricular-Delay in A2A2D mode (donor atrial pacing triggered by recipient atrial sensing or both atria stimulated on demand); in the last 6 consecutive patients a single-chamber pacemaker was implanted with two unipolar leads to the atria connected with a Y adapter programmed in A2A2T mode (both atria were sensed and stimulated by triggering each other).
Signals and thresholds remain stable over time. When clinical and hemodynamic data of 12 A2A2D/T patients with complete 1 year follow-up were compared to age- and sex-matched control HTx recipients with other pacing modes or without pacemakers, a significant benefit of atrial synchronization could be shown regarding rise in heart rate response to exercise (+38% vs 30% vs 16% at 50 watt), New York Heart Association classification (1.6 vs 1.8 vs 2.2), Roskamm staging (1.3 vs 2.5 vs 1.5), cardiac index at rest (3.2 vs 2.78 vs 3.1 L/min x m2), cardiac index at 50 watt (5.5 vs 4.5 vs 5.2 L/min x m2), stroke work at rest (51 vs 38 vs 42 pondmeter [PM]), stroke work at 50 watt (66 vs 48 vs 51 PM), pulmonary wedge pressure at rest (7 vs 13 vs 8 mm Hg) and pulmonary wedge pressure at 50 watt (14 vs 24 vs 18 mm Hg).
It is concluded that electromechanical synchronization of the atria was of long-term benefit in heart transplant recipients with recipient sinus rhythm and donor sinus node disease.
心脏移植(HTx)后的运动能力可能受供体心脏窦房结疾病和房室分离的限制。起搏器治疗在这种情况下的作用尚不明确。本研究的目的是比较接受心房同步起搏治疗的获得性窦房结疾病心脏移植受者与采用其他起搏模式或术后1年未使用起搏器的患者的临床和血流动力学数据。
我们的队列包括1984年至1996年期间的112例心脏移植受者。21例患有供体窦房结疾病且受者为窦性心律的患者接受了心房同步起搏。起搏器植入未伴有相关的发病或死亡情况。14例患者接受了双腔起搏器,以A2A2D模式(由受者心房感知触发供体心房起搏或按需刺激双心房)进行短房室延迟编程;在最后连续6例患者中,植入了单腔起搏器,带有两根单极心房导联,通过Y形适配器连接,以A2A2T模式(双心房相互感知并触发刺激)进行编程。
信号和阈值随时间保持稳定。将12例接受A2A2D/T模式且有完整1年随访的患者的临床和血流动力学数据与年龄和性别匹配的采用其他起搏模式或未使用起搏器的心脏移植对照受者进行比较,结果显示心房同步在运动时心率上升方面有显著益处(50瓦时分别为+38%、30%和16%)、纽约心脏协会分级(分别为1.6、1.8和2.2)、罗斯卡姆分期(分别为1.3、2.5和1.5)、静息时心脏指数(分别为3.2、2.78和3.1L/min·m²)、50瓦时心脏指数(分别为5.5、4.5和5.2L/min·m²)、静息时每搏功(分别为51、38和42pondmeter[PM])、50瓦时每搏功(分别为66、48和51PM)、静息时肺楔压(分别为7、13和8mmHg)以及50瓦时肺楔压(分别为14、24和18mmHg)。
得出结论,心房的机电同步对有受者窦性心律和供体窦房结疾病的心脏移植受者具有长期益处。